Antares Pharma, Inc. (ATRS)

[scubastevo80]

Did anyone see today's news on Teva going for approval for 3x a week methotrexate instead of daily? These patents should not impact Otrexup, correct? Also - does ATRS supply Teva's methotrexate injectors?

"Jan 14 (Reuters) - Teva Pharmaceutical Industries Ltd <TEVA.TA> said on Tuesday it is "completely confident" the new version of its flagship multiple sclerosis drug, Copaxone, which features less frequent dosing, will be approved in the United States in the near future.

The Israel-based company said it believes it will be able to get 45 percent of regular Copaxone patients to switch to the new drug, which is injected three times a week instead of daily."

"Teva executives at the conference said they expect further consolidation in the generic drugs space and said the company still has a sense of urgency when it comes to acquisitions."